Director/PDMR Shareholding

By

Regulatory News | 19 Dec, 2024

Updated : 07:01

RNS Number : 6604Q
M. P. Evans Group PLC
19 December 2024
 

M.P. EVANS GROUP PLC

("Company" or "M.P. Evans")

 

GRANT OF SHARE OPTIONS

 

On 18 December 2024, in line with its policy of deferring half the executive annual bonus into nil-cost share options, the Company granted an option under the M.P. Evans Group PLC Long Term Incentive Scheme to each of Mr Matthew Coulson, the chief executive, and Mr Luke Shaw, the chief financial officer. They may subscribe for 19,376 and 12,986 shares of 10p each respectively in the Company at a nil cost exercise price. No additional performance criteria will attach to the deferred-bonus awards since the original bonuses are performance related. These options are exercisable at any time between 18 December 2027 and 17 December 2034.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended ("UK MAR").

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Matthew Coulson

2

Reason for the notification

a)

Position/status

Chief executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volume


Nil Cost Options

19,376

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

18 December 2024

f)

Place of the transaction

Outside a trading venue

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Luke Shaw

2

Reason for the notification

a)

Position/status

Chief financial officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volume


Nil Cost Options

12,986

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

18 December 2024

f)

Place of the transaction

Outside a trading venue

 

19 December 2024

Enquiries:

 

M.P. Evans Group PLC

Tel: +44 (0)1892 516333

Peter Hadsley-Chaplin - Chairman


Matthew Coulson - Chief executive


Luke Shaw - Chief financial officer




Cavendish Capital Markets Limited (Nomad and broker)

Tel: +44 (0)20 7220 0500

Matt Goode, George Lawson, Rory Sale - Corporate finance

Tim Redfern, Harriet Ward - Equity capital markets




Hudson Sandler (Financial PR)

Tel:  +44 (0)20 7796 4133

Charlie Jack, Francis Kerrigan, Francesca Rosser


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFMFAAELSEFE

Last news